James J. Davis
Impact in
- Molecular Medicine top 0.2%
- Antibiotic Resistance in Bacteria
- Endocrinology top 0.5%
Papers in
-
- Antibiotic Resistance in Bacteria 8
-
- Bacterial Identification and Susceptibility Testing 6
- Co-authors
- Robert OlsonRick StevensFangfang XiaMaulik ShuklaAlice R. WattamRoss OverbeekVeronika VonsteinGordon D. Pusch
- Journals
- Scientific Reports (4 papers)American Journal Of Pathology (3 papers)mSystems (3 papers)Frontiers in Microbiology (3 papers)mBio (2 papers)
- Partner nations
- United StatesDenmarkUnited Kingdom
In The Last Decade
James J. Davis
33 papers receiving 7.0k citations
Hit Papers
Peers
Comparison fields: 5 of 146
- Molecular Medicine 1.2k
- Endocrinology 848
- Ecology 2.4k
- Microbiology 468
- Clinical Biochemistry 496
Countries citing papers authored by James J. Davis
This map shows the geographic impact of James J. Davis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James J. Davis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James J. Davis more than expected).
Fields of papers citing papers by James J. Davis
This network shows the impact of papers produced by James J. Davis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James J. Davis. The network helps show where James J. Davis may publish in the future.
Co-authors
The 25 scholars most cited alongside James J. Davis, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 0 | |
| 2 | Multiple spillovers from humans and onward transmission of SARS-CoV-2 in white-tailed deer Hit paper breakdown → | 2022 | 124 |
| 3 | 2022 | 2 | |
| 4 | 2022 | 19 | |
| 5 | 2022 | 13 | |
| 6 | Signals of Significantly Increased Vaccine Breakthrough, Decreased Hospitalization Rates, and Less Severe Disease in Patients with Coronavirus Disease 2019 Caused by the Omicron Variant of Severe Acute Respiratory Syndrome Coronavirus 2 in Houston, Texas Hit paper breakdown → | 2022 | 127 |
| 7 | 2021 | 10 | |
| 8 | 2020 | 18 | |
| 9 | 2020 | 13 | |
| 10 | 2018 | 182 | |
| 11 | 2018 | 123 | |
| 12 | 2017 | 41 | |
| 13 | 2017 | 52 | |
| 14 | 2016 | 5 | |
| 15 | Space, Labor Markets, and History: An Exploration of American Indian Employment Hardship and Socioeconomic Inequality | 2015 | 1 |
| 16 | RASTtk: A modular and extensible implementation of the RAST algorithm for building custom annotation pipelines and annotating batches of genomes Hit paper breakdown → | 2015 | 1988 |
| 17 | 2014 | 4 | |
| 18 | 2013 | 4 | |
| 19 | The SEED and the Rapid Annotation of microbial genomes using Subsystems Technology (RAST) Hit paper breakdown → | 2013 | 3521 |
| 20 | 2009 | 30 |
About James J. Davis
James J. Davis is a scholar working on Molecular Medicine, Clinical Biochemistry, Infectious Diseases, Molecular Biology and Animal Science and Zoology, having authored 35 papers that have together received 7.1k indexed citations. Recurring topics across this work include Genomics and Phylogenetic Studies (20 papers), Antibiotic Resistance in Bacteria (8 papers), SARS-CoV-2 and COVID-19 Research (6 papers), Bacterial Identification and Susceptibility Testing (6 papers), Microbial Metabolic Engineering and Bioproduction (5 papers), RNA and protein synthesis mechanisms (5 papers), Viral gastroenteritis research and epidemiology (4 papers) and Bacteriophages and microbial interactions (4 papers). The work is most often cited by research in Molecular Medicine (1.2k citations), Endocrinology (848 citations), Ecology (2.4k citations), Microbiology (468 citations) and Clinical Biochemistry (496 citations). James J. Davis has collaborated with scholars based in United States, Denmark and United Kingdom. Frequent co-authors include Robert Olson, Rick Stevens, Fangfang Xia, Maulik Shukla, Alice R. Wattam, Ross Overbeek, Veronika Vonstein, Gordon D. Pusch, Svetlana Gerdes and Robert A. Edwards. Their work appears in journals such as Scientific Reports, American Journal Of Pathology, mSystems, Frontiers in Microbiology and mBio.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.